valsartan has been researched along with cilostazol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Burgin, K; Daiber, A; Daub, S; Gori, T; Hausding, M; Knorr, M; Kröller-Schön, S; Münzel, T; Oelze, M; Rümmler, R; Sartor, D; Scherhag, A; Schreiner, J; Schuff, A; Schulz, E; Wenzel, P | 1 |
Burgin, K; Daiber, A; Gori, T; Jansen, T; Knorr, M; Kopp, M; Kröller-Schön, S; Münzel, T; Oelze, M; Sartor, D; Scherhag, A; Schulz, E; Stamm, P; Tran, LP; Ullmann, E; Welschof, P | 1 |
1 review(s) available for valsartan and cilostazol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for valsartan and cilostazol
Article | Year |
---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Characterization of new organic nitrate hybrid drugs covalently bound to valsartan and cilostazol.
Topics: Animals; Cilostazol; Male; Nitrates; Oxidative Stress; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Tetrazoles; Valine; Valsartan; Vasoconstriction; Vasodilator Agents | 2012 |
Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and Valsartan.
Topics: Animals; Aorta; Cilostazol; Drug Combinations; Drug Synergism; Male; Metoprolol; Mitochondria, Heart; Nitrates; Oxidative Stress; Rats, Wistar; Tetrazoles; Valsartan; Vasodilator Agents | 2018 |